Journal
CLINICAL INFECTIOUS DISEASES
Volume 73, Issue 5, Pages E1208-E1211Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciaa1803
Keywords
COVID-19; SARS-CoV-2; seasonal coronavirus; antibodies; neutralization
Categories
Funding
- NHS Greater Glasgow and Clyde
- National Institutes of Allergy and Infectious Diseases [R37AI640003, R01AI078788]
- Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health [T32GM007739]
Ask authors/readers for more resources
Although cross-reactive immune responses may affect SARS-CoV-2 susceptibility and disease outcomes, neutralizing activity against SARS-CoV-2 was not detected in prepandemic sera with prior seasonal coronavirus infection.
Cross-reactive immune responses elicited by seasonal coronaviruses might affect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) susceptibility and disease outcomes. We measured neutralizing activity against SARS-CoV-2 in prepandemic sera from patients with prior polymerase chain reaction scan-confirmed seasonal coronavirus infection. Although neutralizing activity against seasonal coronaviruses was detected in nearly all sera, cross-reactive neutralizing activity against SARS-CoV-2 was undetectable.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available